This inventor holds 1 USPTO granted patent. Top assignee: Guangzhou Hanfang Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yaming Han: Innovator in Anti-Cancer Medicaments
Introduction
Yaming Han is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for cancer-related fatigue. His innovative approach has led to the creation of a unique patent that addresses a critical need in cancer care.
Latest Patents
Yaming Han holds a patent for "spore oil and use thereof in preparation of anti-cancer-related fatigue medicaments." This patent describes a method for extracting spore oil, which contains over 90% triglycerides and is free from detectable triterpenoids. The extraction process utilizes supercritical CO2 and involves elution with a silica gel column and a mixed solution of petroleum ether-ethyl acetate. The resulting spore oil has demonstrated high efficacy in alleviating cancer-related fatigue, showcasing good safety profiles for use in medicaments.
Career Highlights
Yaming Han is associated with Guangzhou Hanfang Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in creating effective solutions for patients suffering from the debilitating effects of cancer treatments.
Collaborations
Yaming collaborates with talented individuals in his field, including Lin Cao and Qin Zhang, who contribute to his research endeavors. Their combined expertise enhances the potential for innovative breakthroughs in cancer treatment.
Conclusion
Yaming Han's contributions to the field of anti-cancer medicaments through his patented spore oil formulation highlight his commitment to improving patient care. His work exemplifies the importance of innovation in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile